| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.7M | +0.0% |
| SG&A Expense | $3.0M | +360.4% |
| Operating Income | -$3.0M | +10.9% |
| Net Income | -$10.2M | -187.8% |
| EPS (Basic) | -$0.43 | -115.0% |
| EPS (Diluted) | -$0.43 | -115.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $501K | -90.5% |
| Total Assets | $513K | -90.5% |
| Current Liabilities | $10.3M | -58.4% |
| Total Liabilities | $10.3M | — |
| Stockholders' Equity | -$9.8M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.0M | -586.6% |
| Capital Expenditures | $13K | — |
| Investing Cash Flow | -$788K | +72.3% |
| Financing Cash Flow | $11.0M | +181.2% |
| Free Cash Flow | -$10.0M | — |